Ultrasound treatment improves prospects for men with prostate cancer
A study University College London used an experimental treatment known as Hifu (high-intensity focused ultrasound) to treat areas of cancer that are only a few millimetres in size.
The “focal therapy” technique is similar in principle to the “lumpectomy” operation commonly used as an alternative to a full mastectomy in breast cancer.
Advertisement
Hide AdAdvertisement
Hide AdOne year after treatment none of the 41 men in the trial had incontinence, and just one in 10 suffered from poor erections – both common side effects of conventional treatment. Most (95 per cent) were also cancer-free after a year.
The researchers also concluded that “focal therapy of individual prostate cancer lesions, whether multifocal or unifocal, leads to a low rate of genitourinary side-effects and an encouraging rate of early absence of clinically significant prostate cancer”. Chief researcher Dr Hashim Ahmed said: “We’re optimistic that men diagnosed with prostate cancer may soon be able to undergo a day case surgical procedure, which can be safely repeated once or twice, to treat their condition with very few side-effects. That could mean a significant improvement in their quality of life.”
The results of the first phase of the study were published in the journal Lancet Oncology.